Does polyamine oxidase activity influence the oxidative metabolism of children who suffer of diabetes mellitus?
Diabetes mellitus is a metabolic disease characterized by inadequate secretion of insulin. Polyamine oxidase (PAO), a FAD-containing enzyme is involved in the biodegradation of Sp and Spd, catalyzing the oxidative deamination of Sp and Spd, resulting in production of ammonia (NH(3)), corresponding amino aldehydes and H(2)O(2). Malondialdehyde (MDA) and acrolein (CH2=CHCHO), potentially toxic agents, which induce oxidative stress in mammalian cells, are then spontaneously formed from aminoaldehydes. The main signs of oxidative stress in diabetic children were the values of HbA1c and MDA levels. Polyamines have an insulin-like action. Antiglycation property of spermine and spermidine has been recently confirmed. There are no data in the literature about plasma polyamine oxidase (PAO) activities in children with type 1 diabetes. The idea of this study was to evaluate the polyamine metabolism through the estimation of polyamine oxidase activity. We have study children with newly diagnosed type 1 diabetes mellitus (n = 35, age group of 5-16 years, as well as age-matched healthy control subjects (n = 25). The biochemical investigations were done on diabetic children who have the pathological values of glucose (9.11-17.33 mmol/l) and glycosylated Hb (7.57-14.49% HbA(1c)). The children in the control group have referent values of glucose and glycated hemoglobin (4.11-5.84 mmol/L and HbA(1c) 4.22-6.81% of the total Hb. Glucose levels in blood plasma and glycosylated hemoglobin in erythrocythes hemolysates (HbA1c) were measured by using standard laboratory methods. PAO activity in venous blood plasma and the amount of malondialdehyde (MDA) were measured by the spectrophotometric methods. PAO activity, glycemia, HbA1c and MDA were significantly increased in diabetic children compared to the control subjects. PAO activity in children with type 1 diabetes mellitus was very high. The findings of higher blood HbA(1C) and MDA levels confirm the presence of oxidant stress in children with type 1 diabetes mellitus and demonstrate that PAO activity may participate in these circumstances.
Bjelakovic
G
G
Faculty of Medicine, Institute of Biochemistry, University of Nis, 18000 Nis, Serbia. bjelakovic@junis.ni.ac.rs
Beninati
S
S
Bjelakovic
B
B
Sokolovic
D
D
Jevtovic
T
T
Stojanovic
I
I
Rossi
S
S
Tabolacci
C
C
Kocić
G
G
Pavlovic
D
D
Saranac
Lj
Lj
Zivic
S
S
D000293:Adolescent; D001786:Blood Glucose; D016022:Case-Control Studies; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D008315:Malondialdehyde / Q000097:blood; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000378:metabolism*; D000097667:Polyamine Oxidase
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D008315:Malondialdehyde; D000587:Oxidoreductases Acting on CH-NH Group Donors; D000097667:Polyamine Oxidase
Biochem J. 2003 Feb 15;370(Pt 1):19-28
12477380
Life Sci. 2003 Apr 25;72(23):2603-16
12672506
Clin Chim Acta. 2004 Jun;344(1-2):23-35
15149868
Biochem J. 1999 Mar 1;338 ( Pt 2):317-23
10024506
Biochemistry. 1977 Jan 11;16(1):91-100
12798
Glycobiology. 2004 Jan;14(1):65-72
14551218
Clin Chim Acta. 1986 Mar 28;155(3):275-83
3708856
J Biol Chem. 2001 Dec 14;276(50):46779-91
11577085
Life Sci. 2004 Dec 31;76(7):715-30
15581904
Biochim Biophys Acta. 1998 Apr 28;1406(3):321-6
9630703
J Biol Chem. 1977 Jan 25;252(2):560-2
833144
Hum Exp Toxicol. 2004 Feb;23(2):101-5
15070069
Biochem J. 1986 Aug 15;238(1):43-7
3541909
J Biol Chem. 2007 Mar 16;282(11):8404-13
17189273
Eur J Biochem. 2004 Mar;271(5):877-94
15009201
Essays Biochem. 1987;23:82-115
3331368
Biochem J. 1979 Jan 1;177(1):275-82
106846
Mol Cell Biol. 2007 Jul;27(13):4953-67
17485446
J Biol Chem. 2001 Mar 9;276(10):7507-17
11106655
Biochem J. 1986 Mar 1;234(2):249-62
3087344
Environ Health Prev Med. 2008 Jan;13(1):43-51
19568879
J Biochem. 2006 Feb;139(2):155-60
16452302
Biochem J. 2002 Dec 15;368(Pt 3):673-7
12398765
Circulation. 1996 Sep 15;94(6):1276-82
8822980
C R Seances Soc Biol Fil. 1988;182(2):196-201
2973827
J Biol Chem. 1974 Dec 25;249(24):7717-22
4372216
Biochem J. 1989 May 15;260(1):1-10
2673211
Stroke. 2005 Dec;36(12):2609-13
16269634
Biochem J. 1990 Oct 15;271(2):393-7
2241922
Biochem J. 1992 Sep 1;286 ( Pt 2):413-7
1530574
Am J Physiol. 1996 Apr;270(4 Pt 1):C1105-10
8928738
Am J Physiol Endocrinol Metab. 2008 Jun;294(6):E995-1010
18349109
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):371-6
11752393
J Biol Chem. 2008 Feb 15;283(7):4241-51
18089555
Prog Brain Res. 1995;106:333-44
8584670
Annu Rev Biochem. 1984;53:749-90
6206782
J Biol Chem. 2003 Nov 21;278(47):47181-9
12972423
Glycobiology. 1996 Mar;6(2):121-9
8727784
Biochem J. 1988 Jun 15;252(3):701-7
3138973
Ann Clin Lab Sci. 2006 Spring;36(2):174-8
16682514
J Biol Chem. 2002 Oct 18;277(42):39867-72
12181316
Anal Biochem. 1966 Oct;17(1):38-48
5338902
J Biol Chem. 2004 Sep 17;279(38):40076-83
15252047